6-fluoromevalonolactone has been researched along with Cell Transformation, Neoplastic in 1 studies
*Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuthbert, JA; Lipsky, PE | 1 |
1 other study(ies) available for 6-fluoromevalonolactone and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
Topics: Animals; Carboxy-Lyases; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Cholesterol; DNA Replication; Genes, ras; Humans; Interleukin-3; Kinetics; Mevalonic Acid; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |